Global melanoma incidence was 324,635 in 2020, resulting in 57,043 deaths, while 63,731 NMSC deaths were reported

Perineural invasion of five or more nerves independently linked to local recurrence, disease-specific death, any poor outcome

Proportion receiving treatment within 12 months higher with more severe disease

Patients with nonvisible lesions more likely to have T3 or T4 tumors, positive lymph nodes, higher-risk stage

Cultivated cells have better results than noncultivated ones; both types pigment 80 percent or more where needed

Risks associated with COVID-19 severity

High levels of clear and clear/almost clear skin, significant reductions in psoriasis symptoms reported at one year after initiation

Survival benefit seen for Spanish/Hispanic ethnicity, private insurance, residence in areas of high educational attainment

Cost and noncost barriers more likely for sexual and gender-minority patients with chronic inflammatory skin diseases

Children with atopic dermatitis more likely to have more than one positive patch test result

The pigmentary disorder is linked to a host of autoimmune disorders, ocular and auditory abnormalities, and dermatologic conditions

Area under curve 0.98 for clinical and dermatoscopic examination combined with OCT and 0.77 for clinical and dermatoscopic examination alone

All patients with PN reported itch, pain associated with PN, bleeding or scabbing, and having dry skin

Lower all-cause and cause-specific mortality seen, including from infectious diseases, oncologic diseases, endocrine diseases

Greater improvement seen in disease severity by 12 weeks with ciclosporin, but MTX was superior by 60 weeks

47.2 percent received no treatment on day of diagnosis; by one year, 71.8 percent were not receiving treatment

Independent association with CMD seen for higher PASI, longer disease duration, psoriatic arthritis, hypertension

No difference seen in efficacy for NB-UVB treatment combined with tacrolimus 0.1 percent or calcipotriol/betamethasone dipropionate

HS lesions insensitive to innocuous cold and warmth, noxious heat, and light touch compared with healthy pain-free controls

Vitiligo affects patients' daily lives and well-being; more than half of patients report diagnosed mental health conditions

Differences also seen for microbiomes in those with early- and late-stage melanoma, including higher alpha diversity in early-stage

Similar patterns also observed in C-section-born infants

Navigating the emotional and social challenges and enhancing support strategies for patients with vitiligo